Oleksandr Sverdlov

Oleksandr Sverdlov

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4388594
-
person_outline Oleksandr Sverdlov's MOST POPULAR ARTICLES
1-) Digital therapeutics: an integral component of digital innovation in drug development Clinical Pharmacology & Therapeutics 104 (1), 72-80, 2018
2-) Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile … Clinical therapeutics 34 (3), 654-667, 2012
3-) Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile …G Tong, JS Wang, O Sverdlov, SP Huang, R Slemmon, R Croop, ...Clinical therapeutics 34 (3), 654-667, 2012812012
4-) A roadmap to using randomization in clinical trialsVW Berger, LJ Bour, K Carter, JJ Chipman, CC Everett, N Heussen, ...BMC Medical Research Methodology 21, 1-24, 2021952021
5-) Adaptive randomization for clinical trialsWF Rosenberger, O Sverdlov, F HuJournal of biopharmaceutical statistics 22 (4), 719-736, 2012942012